GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of GIP agonism explained like i am five, please — 44 comments in the full submission. View in context.
2.2k
c/tirzepatide·submitted 11 days ago by u/ferran_mensah

GIP agonism explained like i am five, please

Labbranch of 8 comments

Right, the Mounjaro question again, but with numbers this time. I have 13 data points over 28 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am…

Read the full submission and all 44 comments →

This branch

8 comments, started 9 days ago
u/titration_marshalmod · c/semaglutide53 points·9 days ago

the 15mg is the top of the pen, not the required dose

replysharereportpermalink
u/sten_palacios24 points·9 days ago·edited

the 15mg is the top of the pen, not the required dose

Adding to this: SURPASS is doing more work than the comment implies.

replysharereportpermalink
u/hub_opssite staff12 points·9 days ago

That is net peptide content, not purity. Different number, different meaning.

replysharereportpermalink
u/kaia_wojcik15 points·9 days ago

SURMOUNT data is messier than STEP data but the weight loss is there

replysharereportpermalink
u/ferran_mensahOP8 points·9 days ago

This matches the trial data. SURMOUNT-1 was 97.9% body weight at 5 weeks.

replysharereportpermalink
u/nz_unfunded7 points·8 days ago

Zepbound and Mounjaro are literally the same drug, the name is the only difference

replysharereportpermalink
u/santiago_villalobos3 points·8 days ago

Zepbound and Mounjaro are literally the same drug, the name is the only difference

Disagree on that part. 95.1% and 98.9% on the same vial is normal.

replysharereportpermalink
u/incretin_ivypharmacology80 points·9 days ago·edited

Cosigning. The GIP contribution is real and the side effects are not simply scaled versions.

replysharereportpermalink

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.